PLK2 targets GSK3β to protect against cisplatin-induced acute kidney injury

Xiaona Wei1, Jianping Wu1, Jiajia Li1

  • 1Department of Nephrology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.

Insights

Polo-like kinase 2 (PLK2) protects against cisplatin-induced acute kidney injury (AKI) by reducing apoptosis and oxidative stress. Upregulated PLK2 may serve as a novel therapeutic target for preventing cisplatin nephrotoxicity.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Biochemistry

Background:

  • Cisplatin-induced acute kidney injury (AKI) is a severe condition lacking effective treatments.
  • Polo-like kinase 2 (PLK2) is implicated in various disease processes.
  • Identifying novel therapeutic targets for AKI is crucial.

Purpose of the Study:

  • To investigate the role of PLK2 in cisplatin-induced AKI.
  • To determine if PLK2 could be a potential therapeutic target for cisplatin nephrotoxicity.

Main Methods:

  • Integrated two Gene Expression Omnibus (GEO) datasets for cisplatin-induced AKI models.
  • Verified PLK2 expression in AKI animal and cell models.
  • Utilized siRNAs and inhibitors to suppress PLK2; enforced PLK2 expression.
  • Investigated PLK2's potential phosphorylation of glycogen synthase kinase 3β (GSK3β).

Main Results:

  • PLK2 was significantly upregulated in AKI renal tissues.
  • PLK2 suppression exacerbated cisplatin-induced AKI, increasing apoptosis and oxidative stress.
  • Enforced PLK2 expression protected against cisplatin-induced renal dysfunction.
  • PLK2 potentially phosphorylates GSK3β in AKI pathogenesis.

Conclusions:

  • PLK2 plays a protective role in cisplatin-induced AKI.
  • PLK2 represents a potential therapeutic target for mitigating cisplatin nephrotoxicity.

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
66
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.0K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.4K
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
111
Cytoskeletal Linker Proteins - Plakins01:09

Cytoskeletal Linker Proteins - Plakins

Plakins are large proteins with binding domains for microtubules, microfilaments, intermediate filaments, and membrane-associated protein complexes at cell junctions. Plakin functions are evolutionarily conserved and are primarily involved in organizing the different components of the cytoskeleton by crosslinking them to each other and connecting them to the cell-matrix and cell adhesion complexes. They are also known to interact with signal transducers, serve as scaffolds for signaling...
2.4K